5612617 EFFICACY AND SAFETY OF A SINGLE DOSE OF EXAGAMGLOGENE AUTOTEMCEL FOR TRANSFUSION-DEPENDENT-THALASSEMIA AND SEVERE SICKLE CELL DISEASE

5612617 EFFICACY AND SAFETY OF A SINGLE DOSE OF EXAGAMGLOGENE AUTOTEMCEL FOR TRANSFUSION-DEPENDENT-THALASSEMIA AND SEVERE SICKLE CELL DISEASE

Bibliographic Details
Main Authors:	J. de la Fuente, F. Locatelli, H. Frangoul, S. Corbacioglu, D. Wall, M. Cappellini, M. de Montalembert, A. Kattamis, S. Lobitz, D. Rondelli, S. Sheth, M. Steinberg, M. Walters, Y. Bobruff, C. Simard, Y. Song, L. Zhang, A. Sharma, S. Imren, B. Hobbs, S. Grupp
Format:	Article
Language:	English
Published:	Wiley 2023-04-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000928144.02414.84

Similar Items

S270: TRANSFUSION INDEPENDENCE AFTER EXAGAMGLOGENE AUTOTEMCEL IN PATIENTS WITH TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA
by: Franco Locatelli, et al.
Published: (2023-08-01)

Revolutionizing genetic disease treatment: The case of exagamglogene autotemcel
by: Shuquan Rao, et al.
Published: (2024-05-01)

Drug product attributes predict clinical efficacy in betibeglogene autotemcel gene therapy for β-thalassemia
by: Dustin Whitney, et al.
Published: (2023-12-01)

Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemia
by: Anuraag R. Kansal, et al.
Published: (2021-01-01)

Betibeglogene Autotemcel; A new hope for transfusion dependent beta-thalassaemia
by: Hiba Tariq Wally, et al.
Published: (2023-09-01)

Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent β-Thalassemia (NTDT): Design, Development and Potential Place in Therapy
by: Musallam KM, et al.
Published: (2023-05-01)

Luspatercept for transfusion-dependent β-thalassemia: time to get real
by: Khaled M. Musallam, et al.
Published: (2023-08-01)

Cost/effectiveness of elivaldogene autotemcel vs. hematopoietic stem cells transplantation in patients with cerebral adrenoleukodystrophy (CALD)
by: Minela Vapljanin Muratović, et al.
Published: (2024-04-01)

PB2508: COMPARING DEFINITIONS OF EPISODES OF VASO-OCCLUSION AS ENDPOINTS IN CLINICAL STUDIES OF SICKLE CELL DISEASE
by: Franco Locatelli, et al.
Published: (2023-08-01)

A systematic review of clinical effectiveness and safety for historical and current treatment options for metachromatic leukodystrophy in children, including atidarsagene autotemcel
by: Nigel Armstrong, et al.
Published: (2023-08-01)

A retrospective cohort study of Libmeldy (atidarsagene autotemcel) for MLD: What we have accomplished and what opportunities lie ahead
by: Claire Horgan, et al.
Published: (2023-09-01)

P005: Atidarsagene autotemcel (hematopoietic stem cell–gene therapy) preserves cognitive and motor development in metachromatic leukodystrophy with up to 12 years follow-up*
by: Francesca Fumagalli, et al.
Published: (2024-01-01)

Elivaldogene autotemcel approved for treatment of cerebral adrenoleukodystrophy (CALD) in males: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)
by: Anna I. Scott, et al.
Published: (2023-01-01)

P112: ENERGIZE AND ENERGIZE-T: TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES OF MITAPIVAT IN ADULTS WITH NON--TRANSFUSION-DEPENDENT OR TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA
by: K Kuo, et al.
Published: (2022-01-01)

EHA Research Roadmap on Hemoglobinopathies and Thalassemia: An Update
by: Achille Iolascon, et al.
Published: (2019-06-01)

P1466: EFFECT OF LUSPATERCEPT ON BONE MINERAL DENSITY IN PATIENTS WITH BETA‑THALASSEMIA ENROLLED IN THE PHASE 3 BELIEVE TRIAL
by: Thomas D. Coates, et al.
Published: (2023-08-01)

ENERGIZE AND ENERGIZE-T: TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES OF MITAPIVAT IN ADULTS WITH NON–TRANSFUSION-DEPENDENT OR TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA
by: KH Kuo, et al.
Published: (2021-10-01)

PB2231: RATIONALE FOR THE USE OF COMBINATION CHELATION THERAPY IN PATIENTS WITH THALASSEMIA SYNDROMES OR SICKLE CELL ANEMIA: A SYSTEMATIC LITERATURE REVIEW
by: A. Kattamis, et al.
Published: (2022-06-01)

P1511: EFFICACY AND SAFETY OF COMBINATION IRON CHELATION THERAPY WITH DEFERIPRONE AND DEFERASIROX IN PATIENTS WITH Β-THALASSEMIA MAJOR: A SYSTEMATIC LITERATURE REVIEW
by: A. Piga, et al.
Published: (2022-06-01)

Migration: The aftershocks to the provision of healthcare
by: Stephan Lobitz
Published: (2018-04-01)

Untreated Anemia in Nontransfusion-dependent β-thalassemia: Time to Sound the Alarm
by: Khaled M. Musallam, et al.
Published: (2022-12-01)

Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia
by: Pennell, D.J., et al.
Published: (2010)

COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
by: Alessia Marcon, et al.
Published: (2009-06-01)

Outcome for children with metastatic solid tumors over the last four decades.
by: Stephanie M Perkins, et al.
Published: (2014-01-01)

Continued improvement and normalization of myocardial T2*in patients with beta-thalassemia major treated with deferasirox (Exjade (R)) for up to 3 years
by: Pennell, D., et al.
Published: (2010)

Les dynamiques contemporaines des migrations africaines et haïtiennes vers le Brésil
by: Elie de Montalembert

Dinâmicas contemporâneas da migração africana e haitiana para o Brasil
by: Elie de Montalembert
Published: (2023-03-01)

Remote Sensing and Human Health: New Sensors and New Opportunities
by: Louisa R. Beck, et al.
Published: (2000-06-01)

Are we united enough to come down with common charter of demands: the health professionals’ perspective
by: Antonis Kattamis
Published: (2014-12-01)

S124: ADVERSE EVENTS FOLLOWING COVID-19 VACCINATION IN TRANSFUSION-DEPENDENT -THALASSEMIA PATIENTS
by: P Delaporta, et al.
Published: (2022-01-01)

S273: LONG-TERM ERYTHROID RESPONSE DATA FROM PATIENTS (PTS) WITH NON-TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA (NTDT) RECEIVING LUSPATERCEPT IN THE BEYOND TRIAL
by: Ali T. Taher, et al.
Published: (2023-08-01)

Time to shine : applications of solar energy technology /
by: Grupp, Michael
Published: (c201)

Frozen Charlottes – oder das Überleben der Toten in Wort und Schrift
by: Katja Grupp
Published: (2021-02-01)

The present of the past – the Dynamics of rememberance in Pamjati Pamjati by marija Stepanova
by: Katja Grupp
Published: (2019-12-01)

Die Deutsche Delphi-Studie (P 1968)
by: Hariolf Grupp
Published: (1993-12-01)

P1518: LONG-TERM SAFETY RESULTS OF THE BELIEVE STUDY OF LUSPATERCEPT IN ADULTS WITH ΒETA-THALASSEMIA
by: V. Viprakasit, et al.
Published: (2022-06-01)

Effects of Steroid Hormone Levels on the Ultrasound Appearance of the Preovulatory Endometrium in Controlled Ovarian Hyperstimulation Cycles
by: Aytul Corbacioglu, et al.
Published: (2012-01-01)

CAN WE PREDICT INCIPIENT DIABETES MELLITUS IN PATIENTS WITH TRANSFUSION DEPENDENT β-THALASSEMIA (β-TDT) REFERRED WITH A HISTORY OF PREDIABETES?
by: Vincenzo De Sanctis, et al.
Published: (2024-01-01)

Linguagens e interatividade na educação a distância
by: Elizabeth Rondelli
Published: (2003-10-01)

TV, ficción, realidad, verosimilitud
by: Elizabet Rondelli
Published: (2015-01-01)